nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—CYP2C19—epilepsy syndrome	0.171	0.574	CbGaD
Formoterol—CYP2D6—epilepsy syndrome	0.127	0.426	CbGaD
Formoterol—CYP2A6—Amobarbital—epilepsy syndrome	0.041	0.0897	CbGbCtD
Formoterol—CYP2A6—Propofol—epilepsy syndrome	0.0306	0.0669	CbGbCtD
Formoterol—CYP2A6—Phenobarbital—epilepsy syndrome	0.0292	0.0639	CbGbCtD
Formoterol—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0241	0.0527	CbGbCtD
Formoterol—CYP2C19—Felbamate—epilepsy syndrome	0.0224	0.049	CbGbCtD
Formoterol—CYP2C19—Trimethadione—epilepsy syndrome	0.0224	0.049	CbGbCtD
Formoterol—CYP2A6—Valproic Acid—epilepsy syndrome	0.0219	0.0478	CbGbCtD
Formoterol—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0211	0.046	CbGbCtD
Formoterol—CYP2C9—Trimethadione—epilepsy syndrome	0.0186	0.0407	CbGbCtD
Formoterol—CYP2C19—Clobazam—epilepsy syndrome	0.0183	0.0399	CbGbCtD
Formoterol—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0175	0.0383	CbGbCtD
Formoterol—CYP2C19—Carbamazepine—epilepsy syndrome	0.0151	0.0331	CbGbCtD
Formoterol—CYP2C19—Primidone—epilepsy syndrome	0.0141	0.0309	CbGbCtD
Formoterol—CYP2C19—Phenytoin—epilepsy syndrome	0.0136	0.0297	CbGbCtD
Formoterol—CYP2C19—Propofol—epilepsy syndrome	0.0127	0.0277	CbGbCtD
Formoterol—CYP2C9—Carbamazepine—epilepsy syndrome	0.0126	0.0275	CbGbCtD
Formoterol—CYP2C19—Phenobarbital—epilepsy syndrome	0.0121	0.0264	CbGbCtD
Formoterol—CYP2C9—Primidone—epilepsy syndrome	0.0117	0.0257	CbGbCtD
Formoterol—CYP2C19—Diazepam—epilepsy syndrome	0.0115	0.0251	CbGbCtD
Formoterol—CYP2C9—Phenytoin—epilepsy syndrome	0.0113	0.0247	CbGbCtD
Formoterol—CYP2C19—Zonisamide—epilepsy syndrome	0.0112	0.0245	CbGbCtD
Formoterol—CYP2C9—Propofol—epilepsy syndrome	0.0105	0.023	CbGbCtD
Formoterol—CYP2C9—Phenobarbital—epilepsy syndrome	0.0101	0.022	CbGbCtD
Formoterol—CYP2D6—Propofol—epilepsy syndrome	0.00962	0.021	CbGbCtD
Formoterol—CYP2C9—Diazepam—epilepsy syndrome	0.00953	0.0208	CbGbCtD
Formoterol—CYP2C19—Valproic Acid—epilepsy syndrome	0.00904	0.0198	CbGbCtD
Formoterol—CYP2C19—Topiramate—epilepsy syndrome	0.00816	0.0178	CbGbCtD
Formoterol—CYP2C9—Valproic Acid—epilepsy syndrome	0.00752	0.0164	CbGbCtD
Formoterol—Arformoterol—CYP2C19—epilepsy syndrome	0.000257	0.438	CrCbGaD
Formoterol—Arformoterol—CYP2D6—epilepsy syndrome	0.000191	0.325	CrCbGaD
Formoterol—Labetalol—CYP2D6—epilepsy syndrome	0.000139	0.237	CrCbGaD
Formoterol—Rhinitis—Topiramate—epilepsy syndrome	4.93e-05	0.000255	CcSEcCtD
Formoterol—Back pain—Gabapentin—epilepsy syndrome	4.92e-05	0.000254	CcSEcCtD
Formoterol—Headache—Fosphenytoin—epilepsy syndrome	4.92e-05	0.000254	CcSEcCtD
Formoterol—Nervous system disorder—Valproic Acid—epilepsy syndrome	4.91e-05	0.000254	CcSEcCtD
Formoterol—Palpitations—Pregabalin—epilepsy syndrome	4.9e-05	0.000253	CcSEcCtD
Formoterol—Asthenia—Phenytoin—epilepsy syndrome	4.9e-05	0.000253	CcSEcCtD
Formoterol—Nausea—Midazolam—epilepsy syndrome	4.89e-05	0.000253	CcSEcCtD
Formoterol—Muscle spasms—Gabapentin—epilepsy syndrome	4.89e-05	0.000253	CcSEcCtD
Formoterol—Tachycardia—Valproic Acid—epilepsy syndrome	4.89e-05	0.000253	CcSEcCtD
Formoterol—Diarrhoea—Zonisamide—epilepsy syndrome	4.88e-05	0.000252	CcSEcCtD
Formoterol—Pharyngitis—Topiramate—epilepsy syndrome	4.88e-05	0.000252	CcSEcCtD
Formoterol—Asthenia—Oxcarbazepine—epilepsy syndrome	4.87e-05	0.000252	CcSEcCtD
Formoterol—Pruritus—Clonazepam—epilepsy syndrome	4.86e-05	0.000252	CcSEcCtD
Formoterol—Vomiting—Vigabatrin—epilepsy syndrome	4.86e-05	0.000251	CcSEcCtD
Formoterol—Skin disorder—Valproic Acid—epilepsy syndrome	4.86e-05	0.000251	CcSEcCtD
Formoterol—Urinary tract disorder—Topiramate—epilepsy syndrome	4.85e-05	0.000251	CcSEcCtD
Formoterol—Oedema peripheral—Topiramate—epilepsy syndrome	4.84e-05	0.00025	CcSEcCtD
Formoterol—Cough—Pregabalin—epilepsy syndrome	4.84e-05	0.00025	CcSEcCtD
Formoterol—Pruritus—Phenytoin—epilepsy syndrome	4.83e-05	0.00025	CcSEcCtD
Formoterol—Connective tissue disorder—Topiramate—epilepsy syndrome	4.83e-05	0.00025	CcSEcCtD
Formoterol—Nausea—Levetiracetam—epilepsy syndrome	4.83e-05	0.00025	CcSEcCtD
Formoterol—Rash—Vigabatrin—epilepsy syndrome	4.82e-05	0.000249	CcSEcCtD
Formoterol—Dizziness—Felbamate—epilepsy syndrome	4.82e-05	0.000249	CcSEcCtD
Formoterol—Dermatitis—Vigabatrin—epilepsy syndrome	4.82e-05	0.000249	CcSEcCtD
Formoterol—Urethral disorder—Topiramate—epilepsy syndrome	4.82e-05	0.000249	CcSEcCtD
Formoterol—Pruritus—Oxcarbazepine—epilepsy syndrome	4.81e-05	0.000249	CcSEcCtD
Formoterol—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.8e-05	0.000248	CcSEcCtD
Formoterol—Headache—Vigabatrin—epilepsy syndrome	4.79e-05	0.000248	CcSEcCtD
Formoterol—Hypertension—Pregabalin—epilepsy syndrome	4.79e-05	0.000248	CcSEcCtD
Formoterol—Vomiting—Diazepam—epilepsy syndrome	4.79e-05	0.000248	CcSEcCtD
Formoterol—Tremor—Gabapentin—epilepsy syndrome	4.76e-05	0.000246	CcSEcCtD
Formoterol—Rash—Diazepam—epilepsy syndrome	4.75e-05	0.000246	CcSEcCtD
Formoterol—Dermatitis—Diazepam—epilepsy syndrome	4.74e-05	0.000245	CcSEcCtD
Formoterol—Visual impairment—Topiramate—epilepsy syndrome	4.74e-05	0.000245	CcSEcCtD
Formoterol—Chest pain—Pregabalin—epilepsy syndrome	4.72e-05	0.000244	CcSEcCtD
Formoterol—Myalgia—Pregabalin—epilepsy syndrome	4.72e-05	0.000244	CcSEcCtD
Formoterol—Arthralgia—Pregabalin—epilepsy syndrome	4.72e-05	0.000244	CcSEcCtD
Formoterol—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.72e-05	0.000244	CcSEcCtD
Formoterol—Dizziness—Zonisamide—epilepsy syndrome	4.72e-05	0.000244	CcSEcCtD
Formoterol—Headache—Diazepam—epilepsy syndrome	4.72e-05	0.000244	CcSEcCtD
Formoterol—Anxiety—Pregabalin—epilepsy syndrome	4.71e-05	0.000243	CcSEcCtD
Formoterol—Diarrhoea—Clonazepam—epilepsy syndrome	4.7e-05	0.000243	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.69e-05	0.000242	CcSEcCtD
Formoterol—Hypotension—Valproic Acid—epilepsy syndrome	4.68e-05	0.000242	CcSEcCtD
Formoterol—Asthenia—Carbamazepine—epilepsy syndrome	4.68e-05	0.000242	CcSEcCtD
Formoterol—Agitation—Gabapentin—epilepsy syndrome	4.67e-05	0.000242	CcSEcCtD
Formoterol—Diarrhoea—Phenytoin—epilepsy syndrome	4.67e-05	0.000242	CcSEcCtD
Formoterol—Discomfort—Pregabalin—epilepsy syndrome	4.66e-05	0.000241	CcSEcCtD
Formoterol—Nausea—Fosphenytoin—epilepsy syndrome	4.66e-05	0.000241	CcSEcCtD
Formoterol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.65e-05	0.00024	CcSEcCtD
Formoterol—Angioedema—Gabapentin—epilepsy syndrome	4.65e-05	0.00024	CcSEcCtD
Formoterol—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.64e-05	0.00024	CcSEcCtD
Formoterol—Vomiting—Felbamate—epilepsy syndrome	4.63e-05	0.00024	CcSEcCtD
Formoterol—Dry mouth—Pregabalin—epilepsy syndrome	4.62e-05	0.000239	CcSEcCtD
Formoterol—Pruritus—Carbamazepine—epilepsy syndrome	4.61e-05	0.000238	CcSEcCtD
Formoterol—Rash—Felbamate—epilepsy syndrome	4.6e-05	0.000238	CcSEcCtD
Formoterol—Dermatitis—Felbamate—epilepsy syndrome	4.59e-05	0.000237	CcSEcCtD
Formoterol—Malaise—Gabapentin—epilepsy syndrome	4.59e-05	0.000237	CcSEcCtD
Formoterol—Headache—Felbamate—epilepsy syndrome	4.57e-05	0.000236	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.56e-05	0.000236	CcSEcCtD
Formoterol—Cardiac disorder—Topiramate—epilepsy syndrome	4.56e-05	0.000236	CcSEcCtD
Formoterol—Dizziness—Clonazepam—epilepsy syndrome	4.55e-05	0.000235	CcSEcCtD
Formoterol—Nausea—Vigabatrin—epilepsy syndrome	4.54e-05	0.000235	CcSEcCtD
Formoterol—Vomiting—Zonisamide—epilepsy syndrome	4.54e-05	0.000235	CcSEcCtD
Formoterol—Insomnia—Valproic Acid—epilepsy syndrome	4.53e-05	0.000234	CcSEcCtD
Formoterol—Anaphylactic shock—Pregabalin—epilepsy syndrome	4.53e-05	0.000234	CcSEcCtD
Formoterol—Oedema—Pregabalin—epilepsy syndrome	4.53e-05	0.000234	CcSEcCtD
Formoterol—Asthenia—Lamotrigine—epilepsy syndrome	4.52e-05	0.000234	CcSEcCtD
Formoterol—Dizziness—Phenytoin—epilepsy syndrome	4.52e-05	0.000234	CcSEcCtD
Formoterol—Rash—Zonisamide—epilepsy syndrome	4.5e-05	0.000233	CcSEcCtD
Formoterol—Infection—Pregabalin—epilepsy syndrome	4.5e-05	0.000233	CcSEcCtD
Formoterol—Palpitations—Gabapentin—epilepsy syndrome	4.49e-05	0.000232	CcSEcCtD
Formoterol—Dermatitis—Zonisamide—epilepsy syndrome	4.49e-05	0.000232	CcSEcCtD
Formoterol—Dizziness—Oxcarbazepine—epilepsy syndrome	4.49e-05	0.000232	CcSEcCtD
Formoterol—Nausea—Diazepam—epilepsy syndrome	4.47e-05	0.000231	CcSEcCtD
Formoterol—Headache—Zonisamide—epilepsy syndrome	4.47e-05	0.000231	CcSEcCtD
Formoterol—Dyspnoea—Valproic Acid—epilepsy syndrome	4.46e-05	0.000231	CcSEcCtD
Formoterol—Diarrhoea—Carbamazepine—epilepsy syndrome	4.46e-05	0.000231	CcSEcCtD
Formoterol—Pruritus—Lamotrigine—epilepsy syndrome	4.46e-05	0.00023	CcSEcCtD
Formoterol—Somnolence—Valproic Acid—epilepsy syndrome	4.45e-05	0.00023	CcSEcCtD
Formoterol—Immune system disorder—Topiramate—epilepsy syndrome	4.44e-05	0.00023	CcSEcCtD
Formoterol—Nervous system disorder—Pregabalin—epilepsy syndrome	4.44e-05	0.00023	CcSEcCtD
Formoterol—Cough—Gabapentin—epilepsy syndrome	4.44e-05	0.000229	CcSEcCtD
Formoterol—Mediastinal disorder—Topiramate—epilepsy syndrome	4.43e-05	0.000229	CcSEcCtD
Formoterol—Tachycardia—Pregabalin—epilepsy syndrome	4.42e-05	0.000228	CcSEcCtD
Formoterol—Dyspepsia—Valproic Acid—epilepsy syndrome	4.41e-05	0.000228	CcSEcCtD
Formoterol—Skin disorder—Pregabalin—epilepsy syndrome	4.4e-05	0.000227	CcSEcCtD
Formoterol—Hypertension—Gabapentin—epilepsy syndrome	4.39e-05	0.000227	CcSEcCtD
Formoterol—Vomiting—Clonazepam—epilepsy syndrome	4.37e-05	0.000226	CcSEcCtD
Formoterol—Vomiting—Phenytoin—epilepsy syndrome	4.34e-05	0.000225	CcSEcCtD
Formoterol—Rash—Clonazepam—epilepsy syndrome	4.34e-05	0.000224	CcSEcCtD
Formoterol—Dermatitis—Clonazepam—epilepsy syndrome	4.33e-05	0.000224	CcSEcCtD
Formoterol—Myalgia—Gabapentin—epilepsy syndrome	4.33e-05	0.000224	CcSEcCtD
Formoterol—Arthralgia—Gabapentin—epilepsy syndrome	4.33e-05	0.000224	CcSEcCtD
Formoterol—Chest pain—Gabapentin—epilepsy syndrome	4.33e-05	0.000224	CcSEcCtD
Formoterol—Nausea—Felbamate—epilepsy syndrome	4.33e-05	0.000224	CcSEcCtD
Formoterol—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.32e-05	0.000224	CcSEcCtD
Formoterol—Vomiting—Oxcarbazepine—epilepsy syndrome	4.32e-05	0.000223	CcSEcCtD
Formoterol—Fatigue—Valproic Acid—epilepsy syndrome	4.32e-05	0.000223	CcSEcCtD
Formoterol—Anxiety—Gabapentin—epilepsy syndrome	4.31e-05	0.000223	CcSEcCtD
Formoterol—Dizziness—Carbamazepine—epilepsy syndrome	4.31e-05	0.000223	CcSEcCtD
Formoterol—Diarrhoea—Lamotrigine—epilepsy syndrome	4.31e-05	0.000223	CcSEcCtD
Formoterol—Headache—Clonazepam—epilepsy syndrome	4.31e-05	0.000223	CcSEcCtD
Formoterol—Rash—Phenytoin—epilepsy syndrome	4.31e-05	0.000223	CcSEcCtD
Formoterol—Mental disorder—Topiramate—epilepsy syndrome	4.31e-05	0.000223	CcSEcCtD
Formoterol—Dermatitis—Phenytoin—epilepsy syndrome	4.3e-05	0.000222	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.3e-05	0.000222	CcSEcCtD
Formoterol—Rash—Oxcarbazepine—epilepsy syndrome	4.28e-05	0.000221	CcSEcCtD
Formoterol—Pain—Valproic Acid—epilepsy syndrome	4.28e-05	0.000221	CcSEcCtD
Formoterol—Constipation—Valproic Acid—epilepsy syndrome	4.28e-05	0.000221	CcSEcCtD
Formoterol—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.28e-05	0.000221	CcSEcCtD
Formoterol—Headache—Phenytoin—epilepsy syndrome	4.28e-05	0.000221	CcSEcCtD
Formoterol—Malnutrition—Topiramate—epilepsy syndrome	4.28e-05	0.000221	CcSEcCtD
Formoterol—Discomfort—Gabapentin—epilepsy syndrome	4.28e-05	0.000221	CcSEcCtD
Formoterol—Headache—Oxcarbazepine—epilepsy syndrome	4.26e-05	0.00022	CcSEcCtD
Formoterol—Nausea—Zonisamide—epilepsy syndrome	4.24e-05	0.000219	CcSEcCtD
Formoterol—Dry mouth—Gabapentin—epilepsy syndrome	4.23e-05	0.000219	CcSEcCtD
Formoterol—Hypotension—Pregabalin—epilepsy syndrome	4.23e-05	0.000219	CcSEcCtD
Formoterol—Tension—Topiramate—epilepsy syndrome	4.2e-05	0.000217	CcSEcCtD
Formoterol—Dysgeusia—Topiramate—epilepsy syndrome	4.19e-05	0.000217	CcSEcCtD
Formoterol—Dizziness—Lamotrigine—epilepsy syndrome	4.17e-05	0.000215	CcSEcCtD
Formoterol—Nervousness—Topiramate—epilepsy syndrome	4.16e-05	0.000215	CcSEcCtD
Formoterol—Anaphylactic shock—Gabapentin—epilepsy syndrome	4.15e-05	0.000215	CcSEcCtD
Formoterol—Oedema—Gabapentin—epilepsy syndrome	4.15e-05	0.000215	CcSEcCtD
Formoterol—Vomiting—Carbamazepine—epilepsy syndrome	4.14e-05	0.000214	CcSEcCtD
Formoterol—Back pain—Topiramate—epilepsy syndrome	4.14e-05	0.000214	CcSEcCtD
Formoterol—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.13e-05	0.000213	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.12e-05	0.000213	CcSEcCtD
Formoterol—Infection—Gabapentin—epilepsy syndrome	4.12e-05	0.000213	CcSEcCtD
Formoterol—Muscle spasms—Topiramate—epilepsy syndrome	4.11e-05	0.000213	CcSEcCtD
Formoterol—Rash—Carbamazepine—epilepsy syndrome	4.11e-05	0.000213	CcSEcCtD
Formoterol—Dermatitis—Carbamazepine—epilepsy syndrome	4.11e-05	0.000212	CcSEcCtD
Formoterol—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.09e-05	0.000212	CcSEcCtD
Formoterol—Insomnia—Pregabalin—epilepsy syndrome	4.09e-05	0.000212	CcSEcCtD
Formoterol—Nausea—Clonazepam—epilepsy syndrome	4.08e-05	0.000211	CcSEcCtD
Formoterol—Headache—Carbamazepine—epilepsy syndrome	4.08e-05	0.000211	CcSEcCtD
Formoterol—Nervous system disorder—Gabapentin—epilepsy syndrome	4.07e-05	0.00021	CcSEcCtD
Formoterol—Nausea—Phenytoin—epilepsy syndrome	4.06e-05	0.00021	CcSEcCtD
Formoterol—Tachycardia—Gabapentin—epilepsy syndrome	4.05e-05	0.000209	CcSEcCtD
Formoterol—Dyspnoea—Pregabalin—epilepsy syndrome	4.04e-05	0.000209	CcSEcCtD
Formoterol—Nausea—Oxcarbazepine—epilepsy syndrome	4.04e-05	0.000209	CcSEcCtD
Formoterol—Skin disorder—Gabapentin—epilepsy syndrome	4.03e-05	0.000208	CcSEcCtD
Formoterol—Somnolence—Pregabalin—epilepsy syndrome	4.02e-05	0.000208	CcSEcCtD
Formoterol—Tremor—Topiramate—epilepsy syndrome	4.01e-05	0.000207	CcSEcCtD
Formoterol—Vomiting—Lamotrigine—epilepsy syndrome	4.01e-05	0.000207	CcSEcCtD
Formoterol—Urticaria—Valproic Acid—epilepsy syndrome	3.98e-05	0.000206	CcSEcCtD
Formoterol—Rash—Lamotrigine—epilepsy syndrome	3.97e-05	0.000205	CcSEcCtD
Formoterol—Ill-defined disorder—Topiramate—epilepsy syndrome	3.97e-05	0.000205	CcSEcCtD
Formoterol—Dermatitis—Lamotrigine—epilepsy syndrome	3.97e-05	0.000205	CcSEcCtD
Formoterol—Abdominal pain—Valproic Acid—epilepsy syndrome	3.96e-05	0.000205	CcSEcCtD
Formoterol—Body temperature increased—Valproic Acid—epilepsy syndrome	3.96e-05	0.000205	CcSEcCtD
Formoterol—Headache—Lamotrigine—epilepsy syndrome	3.95e-05	0.000204	CcSEcCtD
Formoterol—Agitation—Topiramate—epilepsy syndrome	3.93e-05	0.000203	CcSEcCtD
Formoterol—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.91e-05	0.000202	CcSEcCtD
Formoterol—Fatigue—Pregabalin—epilepsy syndrome	3.9e-05	0.000202	CcSEcCtD
Formoterol—Hypotension—Gabapentin—epilepsy syndrome	3.88e-05	0.000201	CcSEcCtD
Formoterol—Nausea—Carbamazepine—epilepsy syndrome	3.87e-05	0.0002	CcSEcCtD
Formoterol—Pain—Pregabalin—epilepsy syndrome	3.87e-05	0.0002	CcSEcCtD
Formoterol—Constipation—Pregabalin—epilepsy syndrome	3.87e-05	0.0002	CcSEcCtD
Formoterol—Malaise—Topiramate—epilepsy syndrome	3.86e-05	0.0002	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.78e-05	0.000196	CcSEcCtD
Formoterol—Palpitations—Topiramate—epilepsy syndrome	3.78e-05	0.000196	CcSEcCtD
Formoterol—Insomnia—Gabapentin—epilepsy syndrome	3.75e-05	0.000194	CcSEcCtD
Formoterol—Nausea—Lamotrigine—epilepsy syndrome	3.74e-05	0.000194	CcSEcCtD
Formoterol—Cough—Topiramate—epilepsy syndrome	3.73e-05	0.000193	CcSEcCtD
Formoterol—Feeling abnormal—Pregabalin—epilepsy syndrome	3.73e-05	0.000193	CcSEcCtD
Formoterol—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.7e-05	0.000191	CcSEcCtD
Formoterol—Dyspnoea—Gabapentin—epilepsy syndrome	3.7e-05	0.000191	CcSEcCtD
Formoterol—Hypertension—Topiramate—epilepsy syndrome	3.69e-05	0.000191	CcSEcCtD
Formoterol—Somnolence—Gabapentin—epilepsy syndrome	3.69e-05	0.000191	CcSEcCtD
Formoterol—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.69e-05	0.000191	CcSEcCtD
Formoterol—Dyspepsia—Gabapentin—epilepsy syndrome	3.65e-05	0.000189	CcSEcCtD
Formoterol—Arthralgia—Topiramate—epilepsy syndrome	3.64e-05	0.000188	CcSEcCtD
Formoterol—Myalgia—Topiramate—epilepsy syndrome	3.64e-05	0.000188	CcSEcCtD
Formoterol—Chest pain—Topiramate—epilepsy syndrome	3.64e-05	0.000188	CcSEcCtD
Formoterol—Anxiety—Topiramate—epilepsy syndrome	3.63e-05	0.000188	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.62e-05	0.000187	CcSEcCtD
Formoterol—Discomfort—Topiramate—epilepsy syndrome	3.6e-05	0.000186	CcSEcCtD
Formoterol—Urticaria—Pregabalin—epilepsy syndrome	3.6e-05	0.000186	CcSEcCtD
Formoterol—Asthenia—Valproic Acid—epilepsy syndrome	3.59e-05	0.000186	CcSEcCtD
Formoterol—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.58e-05	0.000185	CcSEcCtD
Formoterol—Fatigue—Gabapentin—epilepsy syndrome	3.58e-05	0.000185	CcSEcCtD
Formoterol—Abdominal pain—Pregabalin—epilepsy syndrome	3.58e-05	0.000185	CcSEcCtD
Formoterol—Body temperature increased—Pregabalin—epilepsy syndrome	3.58e-05	0.000185	CcSEcCtD
Formoterol—Dry mouth—Topiramate—epilepsy syndrome	3.56e-05	0.000184	CcSEcCtD
Formoterol—Pain—Gabapentin—epilepsy syndrome	3.55e-05	0.000184	CcSEcCtD
Formoterol—Constipation—Gabapentin—epilepsy syndrome	3.55e-05	0.000184	CcSEcCtD
Formoterol—Pruritus—Valproic Acid—epilepsy syndrome	3.54e-05	0.000183	CcSEcCtD
Formoterol—Oedema—Topiramate—epilepsy syndrome	3.49e-05	0.000181	CcSEcCtD
Formoterol—Infection—Topiramate—epilepsy syndrome	3.47e-05	0.000179	CcSEcCtD
Formoterol—Diarrhoea—Valproic Acid—epilepsy syndrome	3.43e-05	0.000177	CcSEcCtD
Formoterol—Nervous system disorder—Topiramate—epilepsy syndrome	3.42e-05	0.000177	CcSEcCtD
Formoterol—Feeling abnormal—Gabapentin—epilepsy syndrome	3.42e-05	0.000177	CcSEcCtD
Formoterol—Tachycardia—Topiramate—epilepsy syndrome	3.41e-05	0.000176	CcSEcCtD
Formoterol—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.39e-05	0.000175	CcSEcCtD
Formoterol—Skin disorder—Topiramate—epilepsy syndrome	3.39e-05	0.000175	CcSEcCtD
Formoterol—Hypersensitivity—Pregabalin—epilepsy syndrome	3.33e-05	0.000172	CcSEcCtD
Formoterol—Dizziness—Valproic Acid—epilepsy syndrome	3.31e-05	0.000171	CcSEcCtD
Formoterol—Urticaria—Gabapentin—epilepsy syndrome	3.3e-05	0.00017	CcSEcCtD
Formoterol—Body temperature increased—Gabapentin—epilepsy syndrome	3.28e-05	0.00017	CcSEcCtD
Formoterol—Abdominal pain—Gabapentin—epilepsy syndrome	3.28e-05	0.00017	CcSEcCtD
Formoterol—Hypotension—Topiramate—epilepsy syndrome	3.26e-05	0.000169	CcSEcCtD
Formoterol—Asthenia—Pregabalin—epilepsy syndrome	3.25e-05	0.000168	CcSEcCtD
Formoterol—Pruritus—Pregabalin—epilepsy syndrome	3.2e-05	0.000166	CcSEcCtD
Formoterol—Vomiting—Valproic Acid—epilepsy syndrome	3.18e-05	0.000165	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.18e-05	0.000165	CcSEcCtD
Formoterol—Insomnia—Topiramate—epilepsy syndrome	3.16e-05	0.000163	CcSEcCtD
Formoterol—Rash—Valproic Acid—epilepsy syndrome	3.16e-05	0.000163	CcSEcCtD
Formoterol—Dermatitis—Valproic Acid—epilepsy syndrome	3.15e-05	0.000163	CcSEcCtD
Formoterol—Headache—Valproic Acid—epilepsy syndrome	3.14e-05	0.000162	CcSEcCtD
Formoterol—Dyspnoea—Topiramate—epilepsy syndrome	3.11e-05	0.000161	CcSEcCtD
Formoterol—Somnolence—Topiramate—epilepsy syndrome	3.1e-05	0.000161	CcSEcCtD
Formoterol—Diarrhoea—Pregabalin—epilepsy syndrome	3.1e-05	0.00016	CcSEcCtD
Formoterol—Dyspepsia—Topiramate—epilepsy syndrome	3.07e-05	0.000159	CcSEcCtD
Formoterol—Hypersensitivity—Gabapentin—epilepsy syndrome	3.06e-05	0.000158	CcSEcCtD
Formoterol—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.01e-05	0.000156	CcSEcCtD
Formoterol—Fatigue—Topiramate—epilepsy syndrome	3.01e-05	0.000156	CcSEcCtD
Formoterol—Dizziness—Pregabalin—epilepsy syndrome	2.99e-05	0.000155	CcSEcCtD
Formoterol—Constipation—Topiramate—epilepsy syndrome	2.99e-05	0.000154	CcSEcCtD
Formoterol—Pain—Topiramate—epilepsy syndrome	2.99e-05	0.000154	CcSEcCtD
Formoterol—Asthenia—Gabapentin—epilepsy syndrome	2.98e-05	0.000154	CcSEcCtD
Formoterol—Nausea—Valproic Acid—epilepsy syndrome	2.97e-05	0.000154	CcSEcCtD
Formoterol—Pruritus—Gabapentin—epilepsy syndrome	2.94e-05	0.000152	CcSEcCtD
Formoterol—Vomiting—Pregabalin—epilepsy syndrome	2.88e-05	0.000149	CcSEcCtD
Formoterol—Feeling abnormal—Topiramate—epilepsy syndrome	2.88e-05	0.000149	CcSEcCtD
Formoterol—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.86e-05	0.000148	CcSEcCtD
Formoterol—Rash—Pregabalin—epilepsy syndrome	2.85e-05	0.000148	CcSEcCtD
Formoterol—Dermatitis—Pregabalin—epilepsy syndrome	2.85e-05	0.000147	CcSEcCtD
Formoterol—Diarrhoea—Gabapentin—epilepsy syndrome	2.84e-05	0.000147	CcSEcCtD
Formoterol—Headache—Pregabalin—epilepsy syndrome	2.84e-05	0.000147	CcSEcCtD
Formoterol—Urticaria—Topiramate—epilepsy syndrome	2.77e-05	0.000143	CcSEcCtD
Formoterol—Abdominal pain—Topiramate—epilepsy syndrome	2.76e-05	0.000143	CcSEcCtD
Formoterol—Body temperature increased—Topiramate—epilepsy syndrome	2.76e-05	0.000143	CcSEcCtD
Formoterol—Dizziness—Gabapentin—epilepsy syndrome	2.74e-05	0.000142	CcSEcCtD
Formoterol—Nausea—Pregabalin—epilepsy syndrome	2.69e-05	0.000139	CcSEcCtD
Formoterol—Vomiting—Gabapentin—epilepsy syndrome	2.64e-05	0.000136	CcSEcCtD
Formoterol—Rash—Gabapentin—epilepsy syndrome	2.62e-05	0.000135	CcSEcCtD
Formoterol—Dermatitis—Gabapentin—epilepsy syndrome	2.61e-05	0.000135	CcSEcCtD
Formoterol—Headache—Gabapentin—epilepsy syndrome	2.6e-05	0.000134	CcSEcCtD
Formoterol—Hypersensitivity—Topiramate—epilepsy syndrome	2.57e-05	0.000133	CcSEcCtD
Formoterol—Asthenia—Topiramate—epilepsy syndrome	2.51e-05	0.00013	CcSEcCtD
Formoterol—Pruritus—Topiramate—epilepsy syndrome	2.47e-05	0.000128	CcSEcCtD
Formoterol—Nausea—Gabapentin—epilepsy syndrome	2.47e-05	0.000127	CcSEcCtD
Formoterol—Diarrhoea—Topiramate—epilepsy syndrome	2.39e-05	0.000124	CcSEcCtD
Formoterol—Dizziness—Topiramate—epilepsy syndrome	2.31e-05	0.000119	CcSEcCtD
Formoterol—Vomiting—Topiramate—epilepsy syndrome	2.22e-05	0.000115	CcSEcCtD
Formoterol—Rash—Topiramate—epilepsy syndrome	2.2e-05	0.000114	CcSEcCtD
Formoterol—Dermatitis—Topiramate—epilepsy syndrome	2.2e-05	0.000114	CcSEcCtD
Formoterol—Headache—Topiramate—epilepsy syndrome	2.19e-05	0.000113	CcSEcCtD
Formoterol—Nausea—Topiramate—epilepsy syndrome	2.07e-05	0.000107	CcSEcCtD
Formoterol—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	1.01e-05	0.000202	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CCR3—epilepsy syndrome	1e-05	0.0002	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—HTR2A—epilepsy syndrome	1e-05	0.0002	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—CCR5—epilepsy syndrome	1e-05	0.0002	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—NT5E—epilepsy syndrome	9.98e-06	0.000199	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ALAD—epilepsy syndrome	9.98e-06	0.000199	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ADSL—epilepsy syndrome	9.92e-06	0.000198	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—NT5E—epilepsy syndrome	9.89e-06	0.000197	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ALAD—epilepsy syndrome	9.89e-06	0.000197	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CCR3—epilepsy syndrome	9.82e-06	0.000196	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—HTR2A—epilepsy syndrome	9.81e-06	0.000196	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NPY—epilepsy syndrome	9.78e-06	0.000195	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ATP2A2—epilepsy syndrome	9.78e-06	0.000195	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GLUL—epilepsy syndrome	9.73e-06	0.000194	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NPY—epilepsy syndrome	9.57e-06	0.000191	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—ATP2A2—epilepsy syndrome	9.57e-06	0.000191	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	9.55e-06	0.000191	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—AGT—epilepsy syndrome	9.52e-06	0.00019	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	9.52e-06	0.00019	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	9.52e-06	0.00019	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CRH—epilepsy syndrome	9.44e-06	0.000188	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HSPB1—epilepsy syndrome	9.44e-06	0.000188	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CXCL2—epilepsy syndrome	9.44e-06	0.000188	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—OXT—epilepsy syndrome	9.44e-06	0.000188	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CCL3—epilepsy syndrome	9.44e-06	0.000188	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	9.44e-06	0.000188	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	9.44e-06	0.000188	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	9.31e-06	0.000186	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—AGT—epilepsy syndrome	9.31e-06	0.000186	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—CCR5—epilepsy syndrome	9.31e-06	0.000186	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	9.23e-06	0.000184	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—OXT—epilepsy syndrome	9.23e-06	0.000184	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CXCL2—epilepsy syndrome	9.23e-06	0.000184	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CCL3—epilepsy syndrome	9.23e-06	0.000184	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CRH—epilepsy syndrome	9.23e-06	0.000184	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HSPB1—epilepsy syndrome	9.23e-06	0.000184	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CYP2D6—epilepsy syndrome	9.17e-06	0.000183	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ADSL—epilepsy syndrome	9.13e-06	0.000182	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—HTR2A—epilepsy syndrome	9.11e-06	0.000182	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—CCR5—epilepsy syndrome	9.11e-06	0.000182	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ADSL—epilepsy syndrome	9.05e-06	0.000181	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GLUL—epilepsy syndrome	8.95e-06	0.000179	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	8.93e-06	0.000178	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—HTR2A—epilepsy syndrome	8.91e-06	0.000178	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GLUL—epilepsy syndrome	8.87e-06	0.000177	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—PRKCB—epilepsy syndrome	8.8e-06	0.000176	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	8.78e-06	0.000175	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TSC1—epilepsy syndrome	8.77e-06	0.000175	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PTK2B—epilepsy syndrome	8.77e-06	0.000175	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—ADRA2A—epilepsy syndrome	8.73e-06	0.000174	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	8.71e-06	0.000174	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—BCHE—epilepsy syndrome	8.69e-06	0.000173	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—AQP1—epilepsy syndrome	8.67e-06	0.000173	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—AGT—epilepsy syndrome	8.64e-06	0.000173	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—PRKCB—epilepsy syndrome	8.6e-06	0.000172	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TSC1—epilepsy syndrome	8.58e-06	0.000171	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PTK2B—epilepsy syndrome	8.58e-06	0.000171	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SST—epilepsy syndrome	8.53e-06	0.00017	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CCR2—epilepsy syndrome	8.53e-06	0.00017	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NTRK2—epilepsy syndrome	8.53e-06	0.00017	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—DUSP6—epilepsy syndrome	8.46e-06	0.000169	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—AGT—epilepsy syndrome	8.46e-06	0.000169	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ADRA2A—epilepsy syndrome	8.35e-06	0.000167	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CCR2—epilepsy syndrome	8.35e-06	0.000167	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NTRK2—epilepsy syndrome	8.35e-06	0.000167	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SST—epilepsy syndrome	8.35e-06	0.000167	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	8.33e-06	0.000166	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PLAT—epilepsy syndrome	8.32e-06	0.000166	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—SLC2A1—epilepsy syndrome	8.29e-06	0.000165	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—DUSP6—epilepsy syndrome	8.28e-06	0.000165	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	8.22e-06	0.000164	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PLCB1—epilepsy syndrome	8.2e-06	0.000164	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—ADRA2A—epilepsy syndrome	8.17e-06	0.000163	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—TH—epilepsy syndrome	8.17e-06	0.000163	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	8.15e-06	0.000163	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PLAT—epilepsy syndrome	8.14e-06	0.000162	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—BDKRB2—epilepsy syndrome	8.02e-06	0.00016	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CXCL12—epilepsy syndrome	8.02e-06	0.00016	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—POMC—epilepsy syndrome	8.01e-06	0.00016	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—PRKCB—epilepsy syndrome	7.99e-06	0.000159	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—AQP1—epilepsy syndrome	7.98e-06	0.000159	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—IL6ST—epilepsy syndrome	7.96e-06	0.000159	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—AQP1—epilepsy syndrome	7.91e-06	0.000158	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CNR1—epilepsy syndrome	7.88e-06	0.000157	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—JUNB—epilepsy syndrome	7.88e-06	0.000157	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CXCL12—epilepsy syndrome	7.85e-06	0.000157	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—BDKRB2—epilepsy syndrome	7.85e-06	0.000157	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PLCB1—epilepsy syndrome	7.85e-06	0.000157	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	7.84e-06	0.000157	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	7.84e-06	0.000157	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—POMC—epilepsy syndrome	7.84e-06	0.000156	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—PRKCB—epilepsy syndrome	7.81e-06	0.000156	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—IL6ST—epilepsy syndrome	7.78e-06	0.000155	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—JUNB—epilepsy syndrome	7.7e-06	0.000154	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CNR1—epilepsy syndrome	7.7e-06	0.000154	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HTR7—epilepsy syndrome	7.68e-06	0.000153	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PLCB1—epilepsy syndrome	7.68e-06	0.000153	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	7.59e-06	0.000152	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HTR7—epilepsy syndrome	7.52e-06	0.00015	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HBEGF—epilepsy syndrome	7.46e-06	0.000149	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AKT3—epilepsy syndrome	7.32e-06	0.000146	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.3e-06	0.000146	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HBEGF—epilepsy syndrome	7.3e-06	0.000146	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—POMC—epilepsy syndrome	7.28e-06	0.000145	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	7.21e-06	0.000144	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	7.21e-06	0.000144	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AKT3—epilepsy syndrome	7.16e-06	0.000143	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	7.16e-06	0.000143	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—ADAM10—epilepsy syndrome	7.15e-06	0.000143	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	7.15e-06	0.000143	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	7.15e-06	0.000143	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	7.12e-06	0.000142	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—POMC—epilepsy syndrome	7.12e-06	0.000142	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	7e-06	0.00014	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	6.96e-06	0.000139	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	6.82e-06	0.000136	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	6.76e-06	0.000135	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—CAT—epilepsy syndrome	6.73e-06	0.000134	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	6.7e-06	0.000134	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	6.68e-06	0.000133	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	6.66e-06	0.000133	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	6.62e-06	0.000132	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	6.55e-06	0.000131	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	6.54e-06	0.000131	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	6.54e-06	0.00013	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	6.53e-06	0.00013	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	6.47e-06	0.000129	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	6.39e-06	0.000128	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	6.33e-06	0.000126	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	6.19e-06	0.000124	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.15e-06	0.000123	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	6.12e-06	0.000122	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—GPX1—epilepsy syndrome	6.08e-06	0.000121	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	5.98e-06	0.000119	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	5.95e-06	0.000119	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	5.93e-06	0.000118	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	5.92e-06	0.000118	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	5.88e-06	0.000117	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	5.83e-06	0.000116	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	5.82e-06	0.000116	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	5.8e-06	0.000116	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	5.79e-06	0.000116	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	5.73e-06	0.000114	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	5.72e-06	0.000114	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	5.7e-06	0.000114	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	5.68e-06	0.000113	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	5.65e-06	0.000113	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	5.65e-06	0.000113	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	5.61e-06	0.000112	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.6e-06	0.000112	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	5.59e-06	0.000112	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	5.59e-06	0.000112	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	5.53e-06	0.00011	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	5.5e-06	0.00011	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	5.38e-06	0.000107	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	5.38e-06	0.000107	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—AGT—epilepsy syndrome	5.34e-06	0.000106	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	5.32e-06	0.000106	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—BCHE—epilepsy syndrome	5.3e-06	0.000106	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	5.26e-06	0.000105	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—APOE—epilepsy syndrome	5.23e-06	0.000104	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	5.11e-06	0.000102	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.11e-06	0.000102	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	5.11e-06	0.000102	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	5.1e-06	0.000102	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	5.05e-06	0.000101	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	5e-06	9.99e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	5e-06	9.98e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	5e-06	9.98e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	5e-06	9.97e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—TH—epilepsy syndrome	4.98e-06	9.94e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.9e-06	9.79e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	4.9e-06	9.79e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	4.89e-06	9.77e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	4.89e-06	9.77e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—BCHE—epilepsy syndrome	4.87e-06	9.73e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	4.85e-06	9.68e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—BCHE—epilepsy syndrome	4.83e-06	9.64e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	4.8e-06	9.57e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	4.72e-06	9.42e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	4.7e-06	9.38e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	4.65e-06	9.28e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	4.62e-06	9.21e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	4.61e-06	9.2e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	4.6e-06	9.18e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	4.6e-06	9.18e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—TH—epilepsy syndrome	4.58e-06	9.15e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	4.56e-06	9.1e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—TH—epilepsy syndrome	4.54e-06	9.07e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—POMC—epilepsy syndrome	4.49e-06	8.96e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.47e-06	8.93e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	4.3e-06	8.58e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	4.21e-06	8.4e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	4.2e-06	8.39e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	4.16e-06	8.3e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	4.11e-06	8.21e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—CAT—epilepsy syndrome	4.1e-06	8.19e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—ALB—epilepsy syndrome	4.09e-06	8.17e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	3.99e-06	7.97e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	3.82e-06	7.63e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	3.8e-06	7.59e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	3.79e-06	7.57e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—CAT—epilepsy syndrome	3.77e-06	7.53e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—CAT—epilepsy syndrome	3.74e-06	7.47e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	3.72e-06	7.42e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—GPX1—epilepsy syndrome	3.71e-06	7.4e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	3.67e-06	7.33e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	3.64e-06	7.26e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	3.58e-06	7.15e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	3.53e-06	7.04e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	3.46e-06	6.91e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	3.45e-06	6.89e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—GPX1—epilepsy syndrome	3.41e-06	6.81e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	3.38e-06	6.76e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—GPX1—epilepsy syndrome	3.38e-06	6.75e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—AGT—epilepsy syndrome	3.25e-06	6.49e-05	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.21e-06	6.41e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—APOE—epilepsy syndrome	3.19e-06	6.36e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	3.18e-06	6.35e-05	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.14e-06	6.27e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	3.11e-06	6.21e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	3.09e-06	6.17e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	3.02e-06	6.04e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	3.01e-06	6e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.99e-06	5.97e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.97e-06	5.92e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	2.94e-06	5.87e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.93e-06	5.85e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	2.92e-06	5.82e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—APOE—epilepsy syndrome	2.91e-06	5.8e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	2.85e-06	5.7e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	2.77e-06	5.53e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—POMC—epilepsy syndrome	2.74e-06	5.47e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	2.71e-06	5.41e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	2.7e-06	5.39e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	2.64e-06	5.27e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—POMC—epilepsy syndrome	2.52e-06	5.03e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.5e-06	4.98e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—ALB—epilepsy syndrome	2.5e-06	4.98e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—ALB—epilepsy syndrome	2.3e-06	4.58e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—ALB—epilepsy syndrome	2.28e-06	4.54e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	2.18e-06	4.36e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	2.01e-06	4.01e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.99e-06	3.97e-05	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—AKT1—epilepsy syndrome	1.8e-06	3.59e-05	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	1.72e-06	3.44e-05	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	1.69e-06	3.36e-05	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—AKT1—epilepsy syndrome	1.1e-06	2.19e-05	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1.01e-06	2.02e-05	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1e-06	2e-05	CbGpPWpGaD
